Topical DMSO treatment of macular and papular amyloidosis;Lokale DMSO-Behandlung der makulosen und papulosen Amyloidose

Hautarzt

Volumn 48, Issue 1, 1997, Pages 31-37

  Özkaya Bayazit, Esen ^a   Baykal, Can ^a   Kavak, Ayse ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

biphasic amyloidosis; dimethyl sulphoxide (DMSO); lichen amyloidosus; macular amyloidosis; therapy

Indexed keywords

DIMETHYL SULFOXIDE; ANTIINFLAMMATORY AGENT;

ADULT; AMYLOIDOSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LICHEN; MALE; TOPICAL DRUG ADMINISTRATION; ERYTHEMATOSQUAMOUS SKIN DISEASE; FOLLOW UP; LICHENOID ERUPTION; MIDDLE AGED; PATHOLOGY; SKIN; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; AMYLOIDOSIS; ANTI-INFLAMMATORY AGENTS; DIMETHYL SULFOXIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LICHENOID ERUPTIONS; MALE; MIDDLE AGED; SKIN; SKIN DISEASES, PAPULOSQUAMOUS; TREATMENT OUTCOME;

EID: 0031050554     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050050543     Document Type: Article

References (42)

1. Aram H (1986) Failure of etretinate (Ro 10-9359) in lichen amyloidosus. Int J Dermatol 25-206
2. Black MM (1992) Amyloid and the amyloidosis of the skin. In: Champion RH, Burton JL, Ebling FJG (eds) Textbook of dermatology. 5. Aufl, Blackwell Scientific Publications, Oxford, pp 2333-2344
3. Bonnetblanc JM, Bedane C (1991) Regression of scleromyxedema with topical betamethasone and dimethyl sulphoxide: a 30-month followup. Arch Dermatol 127:1733-1734
4. Bonnetblanc JM, Gatanzano G, Roux I (1980) DMSO and macular amyloidosis. Acta Derm Venereol (Stockh) 60:91
5. Breathnach SE (1993) Amyloidosis of the skin. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF (eds) Dermatology in general medicine 4 Aufl, McGraw-Hill, New York, pp 1849
6. Brobyn RD (1975) The human toxicology of dimethyl sulphoxide. Ann NY Acad Sci 243:497-506
7. Brownstein MH, Hashimoto K, Greenwald G (1973) Biphasic amyloidosis: Link between macular and lichenoid forms. Br J Dermatol 88 25-29
8. Cerroni L, Kopera D, Soyer HP, Kerl H (1993) Notalgia parästhetica,"posterior pigmented pruritic patch" and makulöse Amyloidose. Hautarzt 44:777-780
9. Council on Scientific Affairs (1982) Dimethyl sulphoxide. JAMA 248:1369-1371
10. David NA (1972) The pharmacology of dimethyl sulphoxide. Ann Rev Pharmacol 12:353-374
11. Gordon DM, Kleberger KE (1968) The effect of dimethyl sulphoxide (DMSO) on animal and human eyes. Arch Ophthalmol (Chicago) 79:423-427
12. Gürsoy EO, Baykal C, Ozturk S, Sevin P, Ozarmagan G (1992) Kronik aktif hepatit zemininde prurigo nodülaris ve maküler amiloidoz. Den Hast Frengi Ars 26:275-279
13. Herman D (1980) Secondary amyloidosis and antioxidants. Lancet 1:593
14. Hasbimoto K, Ito K, Kumakiri M, Headington J (1987) Nylon brush macular amyloidosis. Arch Dermatol 123:633-637
15. Hintner H, Stössl H, Höpfl R, Grubauer G, Fritsch P (1988) Amyloid K. Hautarzt 39:419-425
16. Hudson LD (1986) Macular amyloidosis: treatment with ultraviolet B. Cutis 38:61-62
17. Iwasaki K, Mihara M, Nishiura S, Shimao S (1991) Biphasic amyloidosis arising from friction melanosis. J Dermatol 18:86-91
18. Jacob SW, Wood DC (1971) Dimethyl sulphoxide (DMSO)-A status report. Clin Med 78:21-31
19. John H, Laudahn G (1967) Clinical experiences with the topical application of DMSO in orthopedic diseases: evaluation of 4180 cases. Ann NY Acad Sci 15:506-516
20. Kedar (Keizman) I, Greenwald M, Ravid M (1977) Treatment of experimental murine amyloidosis with DMSO. Eur J Clin Invest 7:149-150
21. Kleinhans D (1985) Kontakturtikaria. Dermatosen 33:198-203
22. Kligman AM (1965) Topical pharmacology and toxicology of dimethyl sulphoxide Part 1. JAMA 193:796-804
23. Kligman AM (1965) Topical pharmacology and toxicology of dimethyl sulphoxide-Part 2. JAMA 193:923-928
24. Lim KB, Tan SH, Tan KT (1988) Lack of effect of dimethyl sulphoxide (DMSO) on amyloid deposits in lichen amyloidosis. Br J Dermatol 119:409-410
25. Maeda H, Otha S, Saito Y, Nameki H, Ishikawa H (1982) Epidermal origin of the amyloid in localized cutaneous amyloidosis. Br J Dermatol 106:345-351
26. Manabe T, Inagaki Y, Nakagawa S, Miyoshi K, Ueki H (1987) Ripple pigmentation of the neck in atopic dermatitis. Am J Dermatopathol 9:301-307
27. Monfrecola G, Iandoli R, Bruno G, Martellotta D (1985) Lichen amyloidosis: a new therapeutic approach. Acta Derm Venereol (Stockh) 65:453-455
28. Mosher DB, Fitzpatrick TB, Hori Y, Ortonne J-P (1993) Disorders of pigmentation. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF (eds) Dermatology of general medicine,4 Auflage. McGraw-Hill, New York, pp 981
29. Ollague W (1987) Primary cutaneous amyloidosis (Letter). Int J Dermatol 26:135
30. Pravata G, Pinto G, Basco M, Noto G, Arico M (1989) Unusual localization of lichen amyloidosis. Acta Derm Venereol (Stockh) 69:259-260
31. Ravid M, Kedar (Keizman) I, Sohar E (1977) Effect of a single dose of DMSO on renal amyloidosis. Lancet 1:730-731
32. Ravid M, Shapira J, Lang R, Kedar I (1982) Prolonged dimethyl sulphoxide treatment in 13 patients with systemic amyloidosis. Ann Rheum Dis 41:587-592
33. Reynolds JEF (1993) Martindalethe extra pharmacopoeia. 30. Aufl, The Pharmaceutical Press, London, pp 1101-1102
34. Rubin LF (1983) Toxicology update of dimethyl sulphoxide. Ann NY Acad Sci 411:6-9
35. Shibuya T, Murakawa M, Tsuda Y, Harada M (1992) Successful treatment of primary amyloidosis with dimethyl sulphoxide and cytoreductive chemotherapy. Intern Meet 31:544-548
36. Van Rijswijk MH, Donker JM, Ruinen L (1979) DMSO in amyloidosis. Lancet 1:207-208
37. Van Rijswijk MH, Ruinen L, Donker AJ, de Blecourt JJ, Mandema E (1983) Dimethyl sulphoxide in the treatment of AA amyioidosis. Ann NY Acad Sci 411:67-83
38. Weyers W (1995) Lichen amyloidosus-Krankheitsentität oder Kratzeffekt. Hautarzt 46:165-172
39. Wang W-J, Lin CS, Wong CK (1986) Response of systemic amyloidosis to dimethyl sulphoxide. J Am Acad Dermatol 15:402-405
40. Wong CK, Lin CS (1988) Friction amyloidosis. Int J Dermatol 27:302-307
41. Wong CK, Lin CS (1988) Remarkable response of lipoid proteinosis to oral dimethyl sulphoxide. Br J Dermatol 119 541-544
42. Yoneda A, Watanable H, Yanagihara M, Mori S (1989) Immunohistochemical staining properties of amyloids with anti-keratin antibodies using formalin-fixed, paraffin embedded sections. J Cutan Pathol 16:133-136